Predictive Oncology Announces Planned European Launch of its ChemoFx® Treatment Selection Marker and Tumor Profiling Assay

Initial plans target European clinical trials while providing standard testing to clinicians for individual patients

There are an estimated 250,000 gynecologic cancers diagnosed annually across Europe

Read more at globenewswire.com